Cormedix Inc (CRMD)
5.28
0.00 (0.00%)
USD |
NASDAQ |
Apr 22, 16:00
5.285
0.00 (0.00%)
Pre-Market: 20:00
Cormedix Price to Book Value: 4.139 for April 22, 2024
Price to Book Value Chart
Historical Price to Book Value Data
Date | Value |
---|---|
April 22, 2024 | 4.139 |
April 19, 2024 | 4.139 |
April 18, 2024 | 4.248 |
April 17, 2024 | 4.264 |
April 16, 2024 | 4.241 |
April 15, 2024 | 4.217 |
April 12, 2024 | 4.578 |
April 11, 2024 | 5.009 |
April 10, 2024 | 4.139 |
April 09, 2024 | 3.723 |
April 08, 2024 | 3.731 |
April 05, 2024 | 3.692 |
April 04, 2024 | 3.496 |
April 03, 2024 | 3.237 |
April 02, 2024 | 3.198 |
April 01, 2024 | 3.269 |
March 28, 2024 | 3.324 |
March 27, 2024 | 3.261 |
March 26, 2024 | 3.222 |
March 25, 2024 | 3.198 |
March 22, 2024 | 3.073 |
March 21, 2024 | 3.057 |
March 20, 2024 | 2.979 |
March 19, 2024 | 3.002 |
March 18, 2024 | 2.979 |
Date | Value |
---|---|
March 15, 2024 | 2.986 |
March 14, 2024 | 3.276 |
March 13, 2024 | 3.057 |
March 12, 2024 | 2.681 |
March 11, 2024 | 2.759 |
March 08, 2024 | 2.885 |
March 07, 2024 | 2.838 |
March 06, 2024 | 2.812 |
March 05, 2024 | 2.780 |
March 04, 2024 | 2.765 |
March 01, 2024 | 2.874 |
February 29, 2024 | 2.773 |
February 28, 2024 | 2.773 |
February 27, 2024 | 2.765 |
February 26, 2024 | 2.592 |
February 23, 2024 | 2.569 |
February 22, 2024 | 2.538 |
February 21, 2024 | 2.546 |
February 20, 2024 | 2.577 |
February 16, 2024 | 2.592 |
February 15, 2024 | 2.561 |
February 14, 2024 | 2.506 |
February 13, 2024 | 2.412 |
February 12, 2024 | 2.577 |
February 09, 2024 | 2.491 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.784
Minimum
Jun 16 2022
14.95
Maximum
Sep 18 2019
4.906
Average
3.857
Median
Jun 16 2021
Price to Book Value Benchmarks
BioXcel Therapeutics Inc | -- |
Assertio Holdings Inc | 0.5983 |
Verastem Inc | 4.279 |
Ocular Therapeutix Inc | 8.277 |
PAVmed Inc | -- |
Price to Book Value Related Metrics
PS Ratio | 4106.33 |
Price | 5.28 |
Earnings Yield | -17.42% |
Market Cap | 290.30M |